Metabolite concentrations (a.u.) of patients with SAH and controls and P values of between-group comparisons
| Territory | Side | All SAH Patients (n = 58) vs Controls | SAH without Impairment (n = 12) vs Control | SAH with Impairment (n = 46) vs SAH without Impairment | SAH with Impairment (n = 46) vs Controls | Controls without SAH (n = 11) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAA | Glx | Cho | Cr | NAA | Glx | Cho | Cr | NAA | Glx | Cho | Cr | NAA | Glx | Cho | Cr | NAA | Glx | Cho | Cr | ||
| ACA | Right | *9.67 | 11.61 | *2.71 | 8.18 | *9.76 | 10.7 | *2.96 | 8.3 | 9.65 | 11.84 | 2.64 | 8.15 | 11.56 | 11.97 | 2.39 | 8.44 | ||||
| *(.00) | (.61) | *(.04) | (.5) | *(.02) | (.13) | *(.01) | (.8) | (.84) | (.12) | (.05) | (.7) | *(.00) | (.85) | (.07) | (.43) | ||||||
| Left | *9.98 | 11.64 | *2.77 | 8.28 | *9.61 | *9.98 | 2.9 | 7.91 | 10.07 | *12.08 | 2.73 | 8.37 | 11.55 | 12.82 | 2.41 | 8.64 | |||||
| *(.02) | (.16) | *(.06) | (.39) | *(.04) | *(.01) | (.07) | (.25) | (.49) | *(.01) | (.4) | (.29) | *(.01) | (.33) | (.06) | (.49) | ||||||
| MCA | Right | 9.24 | 9.06 | 2.28 | 6.61 | *9.33 | 8.26 | 2.4 | 6.6 | 9.22 | 9.26 | 2.25 | 6.61 | 11.13 | 9.64 | 2.02 | 6.78 | ||||
| *(.00) | (.37) | (.09) | (.63) | *(.03) | (.08) | (.09) | (.7) | (.87) | (.14) | (.35) | (.97) | *(.00) | (.55) | (.10) | (.61) | ||||||
| Left | *10.34 | *10.22 | 2.71 | 7.84 | *9.54 | *8.34 | 2.72 | 7.16 | 10.55 | *10.73 | 2.71 | *8.02 | 12.24 | 12.10 | 2.41 | 8.18 | |||||
| *(.01) | *(.02) | (.1) | (.38) | *(.01) | *(.00) | (.26) | (.11) | (.15) | *(.00) | (.95) | *(.04) | *(.01) | *(.03) | (.06) | (.58) | ||||||
| Global | *9.84 | 10.67 | *2.63 | 7.76 | *9.56 | *9.32 | 2.74 | 7.49 | 9.92 | *11.03 | 2.6 | 7.83 | 11.62 | 11.63 | 2.31 | 8.01 | |||||
| *(.00) | (.12) | *(.04) | (.44) | *(.01) | *(.01) | (.07) | (.30) | (.53) | *(.01) | (.36) | (.33) | *(.00) | (.27) | (.06) | (.52) | ||||||
Note:—P values are indicated in brackets.
↵* Significant values.